Pharminent

Approval for biomarker-based Keytruda a US FDA first

US FDA has approved a cancer treatment based on a common biomarker, as opposed to the location in the body where the tumour developed. http://www.in-pharmatechnologist.com/Regulatory-Safety/Approval-for-biomarker-based-Keytruda-a-US-FDA-first

Filed under: Cancer, Immunotherapy